A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis

Ítems similars

• Interferon β-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study
  per: Nikolaus, S, et al.
  Publicat: (2003)
• Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study
  per: Marteau, P, et al.
  Publicat: (2005)
• Sulphasalazine retention enemas in ulcerative colitis: a double-blind trial.
  per: Palmer, K R, et al.
  Publicat: (1981)
• Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial
  per: Kruis, W, et al.
  Publicat: (2009)
• Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial
  per: Van Assche, G, et al.
  Publicat: (2006)